OMNIlife science, Inc., a privately-held, established medical technology company targeting the $15 billion global hip and knee replacement device market, reported today that Rick Epstein has joined OMNI as CEO. Before joining OMNI, Mr. Epstein served as President and CEO of Sonoma Orthopedic Products for 5 years. Prior to Sonoma, Rick held several executive leadership positions in prominent organizations including Baxter International and Cardinal Health.

"We are pleased that Rick is joining the OMNI team as our CEO and member of our Board of Directors," commented Guy Mayer, Executive Chairman of OMNI. "Rick's experience successfully leading medical device companies through new product introductions will bring great value as we begin launching our new OMNIBotics® Active Spacer™ technology for robotically balancing the ligaments in a total knee replacement surgery."

"I'm looking forward to leading OMNI through an exciting growth stage as surgeons, hospitals and surgery centers begin to experience the benefits OMNI's products and services will bring to them," Mr. Epstein stated. "The recent FDA clearance of OMNI's Active Spacer along with the OMNIBotics surgical robot and OMNI's knee implants provide surgeons with the most advanced tools available for balancing soft tissue, implanting total knees and ultimately providing the best possible outcomes for their total knee patients."

ABOUT OMNI 

OMNI is a privately held company with a proprietary robotic platform, OMNIBotics®, which allows surgeons to conduct patient-specific total knee surgery designed to enhance patient satisfaction and reduce hospital costs. In addition, OMNI designs, engineers, manufactures and distributes a wide range of proprietary hip and knee implants and is focused on providing cutting edge technologies to transform outcomes in joint replacement surgery and enhance a surgeon's ability to help patients live active and pain-free lives. For more information about OMNI, please visit www.omnils.com.